333,334 Other targets of signaling pathways Dasatinib, a common drug for targeting SnCs, is a second-generation tyrosine kinase inhibitor that can downregulate the expression of senescence-associated biomarkers, including -galactosidase, p16, and p21
Breast cancer Findings to date on the role of IGF1 in breast cancer development vary depending on the study
Beysen, C., Karpe, F., Fielding, B., Clark, A., Levy, J., & Frayn, K
Given the significant prevalence of diabetes among older adults, zinc supplementation offers an accessible strategy to improve glycemic control, mitigate complications, and enhance overall health and quality of life in this vulnerable population